Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pauleikhoff

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Eye (London, England)|May 21, 2011
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degenerationK Lueck, S Wasmuth, J Williams, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 27, 2019
[Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor(VEGF) treatment of diabetic macular edema in the clinical routine : Comparison between cooperative and unicentric organization of treatment]H Faatz, K Rothaus, D Westhues, et al.
The British Journal of Ophthalmology|July 24, 2001
Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degenerationC G Sauer, K White, H Stöhr, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 13, 2016
[Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice]B Heimes, T Schick, C K Brinkmann, et al.
The British Journal of Ophthalmology|June 21, 2005
Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degenerationA Bindewald, S Schmitz-Valckenberg, J J Jorzik, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
The British Journal of Ophthalmology|August 25, 2006
Evolving European guidance on the medical management of neovascular age related macular degenerationU Chakravarthy, G Soubrane, F Bandello, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 23, 2013
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]D Pauleikhoff, B Bertram, F G Holz, et al.
European Journal of Human Genetics : EJHG|June 15, 2000
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degenerationF Krämer, K White, D Pauleikhoff, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Eye (London, England)|May 21, 2011
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degenerationK Lueck, S Wasmuth, J Williams, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 27, 2019
[Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor(VEGF) treatment of diabetic macular edema in the clinical routine : Comparison between cooperative and unicentric organization of treatment]H Faatz, K Rothaus, D Westhues, et al.
The British Journal of Ophthalmology|July 24, 2001
Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degenerationC G Sauer, K White, H Stöhr, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|February 13, 2016
[Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice]B Heimes, T Schick, C K Brinkmann, et al.
The British Journal of Ophthalmology|June 21, 2005
Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degenerationA Bindewald, S Schmitz-Valckenberg, J J Jorzik, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
The British Journal of Ophthalmology|August 25, 2006
Evolving European guidance on the medical management of neovascular age related macular degenerationU Chakravarthy, G Soubrane, F Bandello, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 23, 2013
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]D Pauleikhoff, B Bertram, F G Holz, et al.
European Journal of Human Genetics : EJHG|June 15, 2000
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degenerationF Krämer, K White, D Pauleikhoff, et al.
Pageof 12